Patents by Inventor Manzoor M. Khan

Manzoor M. Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Histamine derivatives as immune modulators
    Patent number: 4996221
    Abstract: Histamine derivatives are disclosed which find use as effect and tissue-specific immune modulators. Specifically, the primary terminal nitrogen in histamine is derivatized to introduce a variable length side chain having 0 to 1 branch of from 1 to 3 carbons; 0 to 2 non-oxo-carbonyl groups; 0 to 4 heteroatoms, other than the non-oxo carbonyl oxygen; 0 to 1 aryl or alkyl-aryl group; and 0 to 1 functionally bound amino acid, polypeptide, or protein or derivative thereof.
    Type: Grant
    Filed: January 13, 1987
    Date of Patent: February 26, 1991
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Kenneth L. Melmon, Murray Goodman, Manzoor M. Khan, Debra Marr-Leisy, Michael Verlander
  • Histamine derivatives as immune modulators
    Patent number: RE35224
    Abstract: Histamine derivatives are disclosed which find use as effect and tissue-specific immune modulators. Specifically, the primary terminal nitrogen in histamine is derivatized to introduce a variable length side chain having 0 to 1 branch of from 1 to 3 carbons; 0 to 2 non-oxo-carbonyl groups; 0 to 4 heteroatoms, other than the non-oxo carbonyl oxygen; 0 to 1 aryl or alkylaryl group; and 0 to 1 functionally bound amino acid, polypeptide, or protein or derivative thereof.
    Type: Grant
    Filed: February 26, 1993
    Date of Patent: April 30, 1996
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Kenneth L. Melmon, Murray Goodman, Manzoor M. Khan, Debra Marr-Leisy, Michael Verlander